Zhende Medical Co., Ltd. (SHA:603301)
China flag China · Delayed Price · Currency is CNY
82.00
-1.00 (-1.20%)
Nov 17, 2026, 3:00 PM CST

Zhende Medical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,6554,3304,2644,1276,1385,092
Revenue Growth
7.68%1.54%3.32%-32.76%20.54%-51.04%
Gross Profit
1,5621,4311,4141,2772,0751,738
Operating Income
385.35326.11375.05233.3812.89727.2
Net Income
294.8260.82385.17198.4679.88595.86
Earnings Per Share
1.130.991.450.742.872.63
EPS Growth
6.98%-31.72%95.95%-74.22%9.13%-78.96%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Basic Care
878.34
Surgical Infection Control
1,876
Compression Therapy and Immobilization
487.42
Ostomy and Modern Wound Care
758.28
Infection Control Protection
306.11
Other
23.05
Total
4,330

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0591,109828.391,2072,1751,364
Total Debt
1,4191,282588.17636.92605.85848.36
Net Cash (Debt)
-360.13-173.59240.22570.51,569515.16
Net Cash Growth
---57.89%-63.64%204.55%-72.27%
Net Cash Per Share
-1.38-0.660.902.136.622.27

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
479.89538.49461.14452.111,246817.63
Capital Expenditures
-347.42-550.22-769.69-599.24-754.12-695.47
Free Cash Flow
132.47-11.73-308.55-147.13491.92122.16
Free Cash Flow Growth
----302.68%-93.98%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
33.57%33.05%33.16%30.93%33.80%34.14%
Operating Margin
8.28%7.53%8.80%5.65%13.24%14.28%
Pretax Margin
7.62%7.50%11.15%5.30%13.06%16.10%
Profit Margin
6.33%6.02%9.03%4.81%11.08%11.70%
FCF Margin
2.85%-0.27%-7.24%-3.56%8.02%2.40%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.3000.3000.6501.250-0.600
Dividend Per Share Growth
-53.85%-53.85%-48.00%---73.91%
Dividend Yield
0.37%0.40%2.96%5.14%-1.17%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
72.4871.8215.2132.6414.8019.41
Forward PE
44.0942.3412.679.1311.7018.82
P/FCF Ratio
163.34---20.4594.66
PS Ratio
4.654.331.371.571.642.27